Dr. Dayan Goodenowe
Dr. Goodenowe is a PhD neuroscientist, biochemist, synthetic organic chemist, inventor, and clinical research expert. In 1999, he invented and patented a revolutionary ion cyclotron resonance mass spectrometry technology that, for the first time in history, made it possible to comprehensively monitor human biochemistry.
Using this advanced technology, Dr. Goodenowe analyzed blood samples from tens of thousands of persons of all ages, of all races, and from multiple countries. The biochemistry of healthy persons was compared to persons suffering from disease. A diverse range of over 20 diseases from autism to dementia, and from colon cancer to heart disease was studied. The biochemistry of young versus old, and all-cause mortality was studied. This research led to his discovery that early mortality and each human disease has a biochemical prodrome.
A biochemical prodrome is a deviation from health that precedes and is predictive of a future adverse health event such as disease or death.
These discoveries led to an extensive patent portfolio of diagnostic tests for the early detection and screening of diseases such as specific cancers (colon, pancreatic, ovarian, breast, lung, prostate, and many more), autism, multiple sclerosis, Parkinson’s, ALS, Alzheimer’s, dementia, bipolar disease, schizophrenia, unipolar depression, cardiovascular disease, and others. Dr. Goodenowe created the ProdromeSCAN™ blood test which measures all of the key prodrome biomarkers and offers advanced laboratory test interpretation training for health practitioners.
Harnessing the Power of Prodrome Science
Dr. Goodenowe’s discovery of disease prodromes also revealed an opposite truth: people who maintained optimal biochemical health had an extremely low risk of disease – they had biochemical prodromes of health and longevity. The mission of Prodrome Science is to enable each and every person to attain biochemical prodromes of health using scientifically-validated, targeted biochemical nutrition.
Biochemical prodromes of disease are detectable years in advance of disease symptoms. By converting disease prodromes into health prodromes we can prevent future diseases — a victory with no battle.
The most devastating negative health prodrome discovered by Dr. Goodenowe was a deficiency in a critical group of lipids called plasmalogens. Dr. Goodenowe discovered that plasmalogen deficiencies are linked to numerous diseases such as Alzheimer’s, autism, multiple sclerosis, most cancers, and early death.
There is no viable dietary source of plasmalogens to restore plasmalogen deficiencies. Dr. Goodenowe was the first to design, invent, patent, and develop targeted plasmalogen precursors capable of restoring plasmalogens in all cells of the body. Dr. Goodenowe’s plasmalogen precursors have been extensively studied in preclinical and clinical research and are now available as dietary supplements – ProdromeNEURO™ and ProdromeGLIA™. Blood plasmalogen levels can be measured using Dr. Goodenowe’s ProdromeSCAN™ blood test.
The Prodrome Brand Promise
Every Prodrome Science product was created with a singular purpose. And that purpose is YOU. When you see the Dr. Goodenowe approved seal you can trust that this product is the result of a lifetime of acquired knowledge in biochemical mechanisms of health and disease. From the years of research and exhaustive clinical testing to the strict cGMP processes that apply to each step of our product pipeline, our team is dedicated to delivering the best biochemical essentials. Everything that you need and nothing that you don’t. The difference is in every bottle.